Results
1
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
1 companies
Kamada
Market Cap: ₪1.3b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪21.74
7D
0.6%
1Y
-8.6%